Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H25NO.BrH |
Molecular Weight | 352.309 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Br.COC1=CC=C2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)C2=C1
InChI
InChIKey=MISZALMBODQYFT-FLCXFYETSA-N
InChI=1S/C18H25NO.BrH/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18;/h6-7,12,15,17H,3-5,8-11H2,1-2H3;1H/t15-,17+,18+;/m0./s1
Molecular Formula | BrH |
Molecular Weight | 80.912 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C18H25NO |
Molecular Weight | 271.3972 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/21311876https://www.ncbi.nlm.nih.gov/pubmed/27139517Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/26226106 | https://www.ncbi.nlm.nih.gov/pubmed/23628523 | https://www.ncbi.nlm.nih.gov/pubmed/24142584
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21311876https://www.ncbi.nlm.nih.gov/pubmed/27139517
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/26226106 | https://www.ncbi.nlm.nih.gov/pubmed/23628523 | https://www.ncbi.nlm.nih.gov/pubmed/24142584
Racemethorphan is racemic mixture of Dextromethorphan and Levomethorphan. Racemethorphan is listed under the Single Convention on Narcotic Drugs 1961 and is therefore listed in the United States as a Controlled Substance, specifically as a Narcotic in Schedule II. Dextromethorphan is a non-narcotic morphine derivative widely used as an antitussive. Dextromethorphan is a cough suppressant in many over-the-counter cold and cough medicines. In 2010, the FDA approved the combination product dextromethorphan/quinidine for the treatment of pseudobulbar affect. Dextromethorphan suppresses the cough reflex by a direct action on the cough center in the medulla of the brain. Levomethorphan is an opioid analgesic of the morphinan family that has never been marketed.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24142584
Curator's Comment: https://www.ncbi.nlm.nih.gov/pubmed/16634036
Originator
Sources: https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19480415&CC=CH&NR=254106A&KC=Ahttps://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19540415&CC=CH&NR=297994A&KC=A
Curator's Comment: # F. Hoffmann-La Roche & Co., A.-G.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094124 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19345586 |
3360.0 nM [Ki] | ||
Target ID: CHEMBL287 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15723099 |
205.0 nM [Ki] | ||
Target ID: CHEMBL4787 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2897648 |
|||
Target ID: CHEMBL2094124 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19345586 |
3360.0 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21311876 |
Primary | Unknown Approved UseUnknown |
||
PubMed
Title | Date | PubMed |
---|---|---|
Over-the-counter medications for acute cough in children and adults in ambulatory settings. | 2001 |
|
Dystonia as acute adverse reaction to cough suppressant in a 3-year-old girl. | 2001 |
|
The placebo response to citric acid-induced cough: pharmacodynamics and gender differences. | 2001 |
|
Pharmacological control of cough. | 2001 Apr |
|
Chromatographic analysis of phenethylamine-antihistamine combinations using C8, C18 or cyano columns and micellar sodium dodecyl sulfate-pentanol mixtures. | 2001 Apr |
|
Angle closure risk from proprietary medicines. | 2001 Apr |
|
Substrate inhibition kinetics for cytochrome P450-catalyzed reactions. | 2001 Apr |
|
High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. II. Validation of a direct injection/on-line guard cartridge extraction-tandem mass spectrometry method for CYP2D6 inhibition assessment. | 2001 Apr 5 |
|
A fast and efficient determination of amines and preservatives in cough and cold liquid and suspension formulations using a single isocratic ion-pairing high performance [correction of power] liquid chromatography method. | 2001 Aug |
|
The use of genetically engineered cells for assessing CYP2D6-related polymorphic effects. | 2001 Aug-Oct |
|
The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers. | 2001 Dec |
|
Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers. | 2001 Feb |
|
The safety of dextromethorphan in pregnancy : results of a controlled study. | 2001 Feb |
|
Phencyclidine-induced discriminative stimulus is mediated via phencyclidine binding sites on the N-methyl-D-aspartate receptor-ion channel complex, not via sigma(1) receptors. | 2001 Feb 15 |
|
The effect of the NMDA receptor blocker, dextromethorphan, on cribbing in horses. | 2001 Jan |
|
Epidemiologic analysis of prenatal exposure to cough medicines containing dextromethorphan: no evidence of human teratogenicity. | 2001 Jan |
|
Terbinafine-associated inhibition of dextromethorphan metabolism in Chinese subjects. | 2001 Jan |
|
Genetic polymorphism of CYP2D6 in Tamil population. | 2001 Jan-Feb |
|
Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan. | 2001 Jul |
|
NMDA receptor-mediated modulation of ventilation in obese Zucker rats. | 2001 Jul |
|
Increasing bioanalytical throughput using pcSFC-MS/MS: 10 minutes per 96-well plate. | 2001 Jul 1 |
|
Clinical case discussion: anesthesia for Cesarean section in a parturient with a large intrathoracic tumour. | 2001 Jun |
|
Dextromethorphan affects cocaine-mediated behavioral pattern in parallel with a long-lasting Fos-related antigen-immunoreactivity. | 2001 Jun 29 |
|
Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine. | 2001 Jun 29 |
|
Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. | 2001 Jun 29 |
|
Cytochrome P450 expression and related metabolism in human buccal mucosa. | 2001 Mar |
|
Variables in human liver microsome preparation: impact on the kinetics of l-alpha-acetylmethadol (LAAM) n-demethylation and dextromethorphan O-demethylation. | 2001 Mar |
|
Metabolic capacity and interindividual variation in toxicokinetics of styrene in volunteers. | 2001 May |
|
Dextromethorphan is an effective cough suppressant. | 2001 May |
|
Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr. | 2001 May |
|
Cardiovascular sympathomimetic amine interactions in rats treated with monoamine oxidase inhibitors and the novel oxazolidinone antibiotic linezolid. | 2001 May |
|
Abuse of Coricidin HBP cough & cold tablets: episodes recorded by a poison center. | 2001 Oct 1 |
|
Dextromethorphan in pregnancy. | 2001 Sep |
|
The role of ionotropic glutamate receptors in nociception with special regard to the AMPA binding sites. | 2002 |
|
Analgesic effects of dextromethorphan and morphine in patients with chronic pain. | 2002 Apr |
|
Modulation of human corticomotor excitability by somatosensory input. | 2002 Apr 15 |
|
Glutamate-induced excitotoxicity in retina: neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers. | 2002 Feb |
|
Development of a rapid and sensitive high-performance liquid chromatographic method to determine CYP2D6 phenotype in human liver microsomes. | 2002 Feb |
|
Effect of ketamine, dextromethorphan, and MK-801 on cochlear dysfunction induced by transient ischemia. | 2002 Jan |
|
Dextromethorphan can produce false positive phencyclidine testing with HPLC. | 2002 Jan |
|
Inhibition kinetics of monoclonal antibodies against cytochromes P450. | 2002 Jun |
|
Treatment of codeine dependence with inhibitors of cytochrome P450 2D6. | 2002 Jun |
|
CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity. | 2002 Mar |
|
Selective suppression of late laryngeal adductor responses by N-methyl-D-aspartate receptor blockade in the cat. | 2002 Mar |
|
Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. | 2002 Mar 1 |
|
The effects of concomitant administration of theophylline and toborinone on the pharmacokinetics of both compounds in poor and extensive metabolizers via CYP2D6. | 2002 May |
|
Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. | 2002 May |
|
Characterization of cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 activities toward model CYP2D6 substrates dextromethorphan, bufuralol, and debrisoquine. | 2002 May |
|
Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. | 2002 May 11 |
|
Semi-automated liquid--liquid back-extraction in a 96-well format to decrease sample preparation time for the determination of dextromethorphan and dextrorphan in human plasma. | 2002 May 25 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21311876
Levomethorphan (dissolved in a mixed solution of 5% Emulphor™ EL-620/5% ethanol/90% isotonic sodium chloride solution, 2.5 mg/mL, rat 4–6) was administered to male DA pigmented rats, which were 5 weeks old and around 90 g mean weight. The drugs were given once daily at 5 mg/kg by intraperitoneal injection for ten successive days.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21311876
Liver microsomes from individual male dark agouti (DA) rats (n=4, 6 weeks old, around 125 g mean weight) were prepared by ultracentrifugation. For the in vitro experiments with rat and human liver microsomes, the reaction mixture consisted of 0.1 M potassium phosphate buffer (pH 7.4) with an NADPH generating system (1.3 mM NADP, 3.3 mM G-6-P, 0.4 U/ mL G-6-PDH, 3.3 mM MgCl2), 50 μM substrate (dextromethorphan or levomethorphan), and 0.5 mg protein/mL microsomes (rat or human liver microsomes) in a final volume of 200 μL. Dextromethorphan and levomethorphan were dissolved in methanol, and the final concentration of the organic solvent was 0.1%. The incubation was started by adding the microsomal fraction and then continued for 0, 5, 10, or 20 min. The reaction was terminated by adding an equal volume of a mixed organic solution of 50% acetonitrile and 50% methanol, including 10 μM levallorphan (IS), and vigorous shaking.
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:30:21 GMT 2025
by
admin
on
Mon Mar 31 22:30:21 GMT 2025
|
Record UNII |
9YNW43KIJI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID80872363
Created by
admin on Mon Mar 31 22:30:21 GMT 2025 , Edited by admin on Mon Mar 31 22:30:21 GMT 2025
|
PRIMARY | |||
|
9YNW43KIJI
Created by
admin on Mon Mar 31 22:30:21 GMT 2025 , Edited by admin on Mon Mar 31 22:30:21 GMT 2025
|
PRIMARY | |||
|
5486607
Created by
admin on Mon Mar 31 22:30:21 GMT 2025 , Edited by admin on Mon Mar 31 22:30:21 GMT 2025
|
PRIMARY | |||
|
m6790
Created by
admin on Mon Mar 31 22:30:21 GMT 2025 , Edited by admin on Mon Mar 31 22:30:21 GMT 2025
|
PRIMARY | Merck Index | ||
|
125-68-8
Created by
admin on Mon Mar 31 22:30:21 GMT 2025 , Edited by admin on Mon Mar 31 22:30:21 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |